Review: immune thrombocytopenic purpura: an update for immunohematologists
By:
Paid access
|May 2020References
- Nugent DJ. Childhood immune thrombocytopenic purpura. Blood Rev 202;16:27-9.
- Kuhne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the International Childhood ITP Study Group. J Pediatr 203;143:605-8.
- Neylon AJ, Saunders PW, Howard MR, et al. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 203;122:966-74.
- Sandler SG. The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura. Semin Hematol 200;37(suppl 1):10-2.
- Harrington WJ, Minnich V, Hollingsworth JW, et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951;115:636-45.
- McFarland J. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev 202;16:1-2.
- Horsewood P, Keton JG. Macrophage-mediated cell destruction. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1994: 435-64.
- Raife TJ, Olson JD, Lentz SR. Platelet antibody testing in idiopathic thrombocytopenic purpura (letter). Blood 1997;89:112-4.
- McMillan R, Lopez-Dee J, Loftus JC. Autoantibodies to α IIbβ3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on αIIb. Blood 201;97:2171-2.
- Kuwana M, Kaburaki J, Kitasato H, et al. Immunodominant epitopes on glycoproteins IIb- IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood 201;98:130-9.
- McMillan R, Wang L, Tani P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 203;1:485-91.
- Williams Y, Lynch S, McCann S, et al. Correlation of platelet FcγRIIA polymorphism in refractor y idiopathic (immune) thrombocytopenic purpura. Br J Haematol 1998;101:779-82.
- Fujimoto TT, Inoue M, Shimomura T, Fujimura K. Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura. Br J Haematol 201; 115:125-30.
- Chan H, Moore JC, Finch CN, et al. The IgG subclasses of platelet-associated autoantibodies detected against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura. Br J Haematol 203;122:818-24.
- Dixon R, Rosse W, Ebbert L. Quantitative detection of antibody in idiopathic thrombocytopenic purpura. N Engl J Med 1975;292:230-6.
- McMillan R, Longmire R, Yelenosky R, et al. Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombocytopenic purpura. N Engl J Med 1972;286:681-4.
- Zimmerman SA, Malinoski FJ, Ware RE. Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura. Am J Hematol 1998;57:131-8.
- Imbach P, Barandum E, d’Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-30.
- Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. N Engl J Med 1982;306:1254-8.
- Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet 1983;2:193-5.
- Savasman CM, Sandler SG. Serologic aspects of treating immune thrombocytopenic purpura using intravenous Rh immune globulin. Immunohematology 201;17:106-10.
- Sandler SG. Intravenous Rh immune globulin for treating immune thrombocytopenic purpura. Curr Opin Hematol 201;8:417-20.
- Sandler SG. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin. Trans Med Rev 201;15:67-76.
- Sandler SG, Novak SC, Roland B.The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin. Am J Hematol 200;63:245-7.
- Gaines AR. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 200;95:2523-9.
- Sandler SG, Mallory D, Trimble J, Nance ST. Intravenous anti-D treatment of immune thrombocytopenic purpura (letter). Blood 1998;91:2624-5.
- Rushin J, Rumsey DH, Ewing CA, Sandler SG. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin. Transfusion 200;40:551-4.
- Stasi R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 201;98:952-7.
- Bengtson KL, Skinner MA,Ware RE. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenia. J Pediatr 203;143:670-3.
- Gasbarrini A, Franceschi F, Tatagilone R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352-78.
- Emilia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 201;97:812-4.
- Veneri D, Franchini M, Gottardi M,et al. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Br J Haematol 202;118: 1198-9.
- Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondar y autoimmune thrombocytopenic purpura. Br J Haematol 202;118:584-8.
- Hashino S, Mori A, Suzuki S,et al. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol 203;77:188-91.
- Michel M, Cooper N, Jean C, et al. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 204;103: 890-6.
- Jarque I,Andreu R, Llopis I, et al.Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 201; 115:102-3.
- Emilia G, Luppi M, Morselli M, et al. Helicobacter pylori infection and idiopathic thrombocytopenic purpura (correspondence). Br J Haematol 118: 1198-9.
- McCrae KR. Helicobacter pylori and ITP: many questions, few answers. Blood 204;103:752-3.
- Ilver D, Arnqvist A, Ögren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;270: 373-7.
- Heneghen MA, Moran AP, Feeley KM,et al.Effect of host Lewis and ABO blood group antigen expression on Helicobacter pylori colonisation density and the consequent inf lammator y response. FEMS Immunol Med Microbiol 1998;20: 257-66.
- Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. PNAS 96: 12778-83.
- Dunstan RA, Simpson MB. Heterogeneous distribution of antigens on human platelets demonstrated by fluorescence flow cytometry. Br J Haematol 1985;61:603-9.
- McGinniss M. The ubiquitous nature of human blood group antigens as evidenced by bacterial, viral and parasitic infections. In: Garratty G, ed. Blood group antigens and disease. Arlington, VA: American Association of Blood Banks, 1983: 25-43.
DOI: https://doi.org/10.21307/immunohematology-2019-432 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 112 - 117
Published on: May 15, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 S.G. Sandler, published by American National Red Cross
This work is licensed under the Creative Commons License.